Back to Search
JOHN LUKENS, MD
MD
Family Medicine Physician
NPI: 1801089834IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
M13875(ID)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE
Class of 2007
Research & Publications (20)
Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
PMID 19004570·Int J Radiat Oncol Biol Phys·2009
8-other
Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
PMID 18354211·J Immunol·2008
7-preclinical
Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis.
PMID 17322392·Am J Pathol·2007
7-preclinical
Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control.
PMID 17947656·J Immunol·2007
7-preclinical
Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice.
PMID 16280127·Atherosclerosis·2006
7-preclinical
Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage.
PMID 16670334·J Immunol·2006
7-preclinical
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
PMID 16624549·Eur J Cancer·2006
8-other
Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation.
PMID 15894587·J Leukoc Biol·2005
7-preclinical
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
PMID 15549714·Cancer·2005
4-observational
Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice.
PMID 15102879·J Lipid Res·2004
7-preclinical
Effect of measurement on the periodicity of the Coulomb staircase of a superconducting box.
PMID 14995335·Phys Rev Lett·2004
8-other
Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodents.
PMID 18007418·Molecules·2004
7-preclinical
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
PMID 15386308·Cancer·2004
8-other
Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro.
PMID 14595002·J Lipid Res·2004
7-preclinical
Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe.
PMID 12791670·Arterioscler Thromb Vasc Biol·2003
7-preclinical
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
PMID 14601099·Cancer·2003
8-other
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
PMID 12692554·Nat Genet·2003
8-other
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.
PMID 12562837·J Lipid Res·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 301 CEDAR ST
OROFINO, ID 83544 - Phone
- (208) 476-4555
Quick Facts
- NPI
- 1801089834
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile